|1.||Migraine Disorders (Migraine)
|5.||Brain Ischemia (Cerebral Ischemia)
|1.||Strecker, T: 2 articles (06/2003 - 04/2002)|
|2.||Messlinger, K: 2 articles (06/2003 - 04/2002)|
|3.||Sarma, Ganti S: 1 article (04/2015)|
|4.||Goyal, Amit Kumar: 1 article (04/2015)|
|5.||Garg, Tarun: 1 article (04/2015)|
|6.||Rath, Goutam: 1 article (04/2015)|
|7.||Kumar, Animesh: 1 article (04/2015)|
|8.||Papaioannou, George: 1 article (08/2013)|
|9.||Lazopoulos, George: 1 article (08/2013)|
|10.||Kantartzis, Michael: 1 article (08/2013)|
|1.||Pizotyline (BC 105)IBA
01/01/1972 - "Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches."
11/01/1969 - "[Tests of BC 105 in 20 cases of vascular headache]."
01/01/1974 - "A cooperative study on the clinical aspects of migraine and vascular headache and their response to sandomigran."
10/01/1977 - "These properties, and the well-documented effect of pizotifen in migraine, could make it an alternative in treating patients suffering from the often seen combination of vascular headache/depression."
01/01/1990 - "Since the ergot alkaloids possess a similar profile of drug activity, it is suggested that drugs useful in the treatment of acute vascular headaches may share a similar mechanism of action."
12/01/1988 - "Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches."
08/01/1992 - "Moskowitz argues that blockade of neural transmission and the neurogenic inflammatory response provides a mechanism by which sumatriptan and ergot alkaloids alleviate vascular headaches. "
|4.||Methylergonovine (Methergine)FDA LinkGeneric
|5.||gamma-Aminobutyric Acid (GABA)IBA
|6.||Ergotamine (Ergotamine Tartrate)FDA LinkGeneric
02/01/1966 - "A study of a non-ergotamine agent in the office treatment of vascular headache."
08/01/2013 - "Ergotamine is used to abort or prevent vascular headache. "
01/01/2012 - "Ergotamine is a well known pharmacological remedy applied in neurology (treatment of vascular headache) and in obstetrics (abortive remedy, uterus atony). "
06/01/2007 - "Ergotamine has been used for therapeutic purposes since the 1950s, usually to treat vascular headache. "
04/01/1963 - "Ergotamine tartrate in the treatment of vascular headaches."
|7.||Nitric Oxide (Nitrogen Monoxide)FDA Link
08/01/2003 - "The role of nitric oxide in vascular headache."
09/01/1995 - "Nitric oxide (NO) and the dura mater are implicated in the pathogenesis of vascular headache. "
01/12/1994 - "The nitric oxide molecule, a potent vasodilator, may contribute to the vascular headache process by dilating dural vasculature. "
04/01/1995 - "The nitric oxide hypothesis of migraine and other vascular headaches."
05/01/1994 - "Nitric oxide is a key molecule in migraine and other vascular headaches."
|8.||Histamine (Histamine Dihydrochloride)FDA Link
04/01/1980 - "The i.v. histamine infusion test is a useful model for the study of experimental vascular headache."
11/01/1966 - "Intradermal histamine therapy of vascular headache."
01/01/1951 - "Chronic vascular headache treated by intense histamine therapy; therapeutic and side-effects as well as mechanism of histamine treatment."
10/01/1950 - "[Endovenous histamine in treatment of vascular headache]."
08/11/1980 - "[Skin tests, blood histamine level and eosinophilia in vascular headache]."
|9.||Methysergide (Sansert)FDA Link
05/05/1967 - "[Experience with methysergide in 48 cases of vascular headache]."
10/01/1963 - "USE OF METHYSERGIDE IN THE TREATMENT OF EXTRACRANIAL VASCULAR HEADACHE."
01/01/1962 - "Prophylaxis of frequent vascular headache with methysergide."
03/01/1961 - "Evaluation of UML-491 in the treatment of vascular headaches. "
06/01/1963 - "An evaluation of methysergide in the prevention of migraine and other vascular headaches."
|10.||Calcitonin Gene-Related PeptideIBA
02/01/2003 - "Calcitonin gene-related peptide (CGRP) is involved in the underlying pathophysiology of all vascular headaches, including migraines. "
11/01/2002 - "Nitric oxide (NO) and calcitonin-gene-related peptide (CGRP) are implicated in the pathophysiology of vascular headaches. "
06/01/2003 - "Nitric oxide (NO) and calcitonin gene-related peptide (CGRP), potent vasodilators in the meninges,may be involved in the pathophysiology of vascular headaches such as migraine pain. "
04/01/2002 - "This study addresses possible interactions of the vasodilators nitric oxide (NO), calcitonin gene-related peptide (CGRP) and prostaglandins, which may be implicated in the generation of vascular headaches. "
|1.||Psychology Biofeedback (Biofeedback)
03/01/1983 - "Vascular headache patients low in absorption were significantly improved after biofeedback training. "
03/01/1983 - "Vascular headache patients high in absorption were significantly improved following relaxation training, but not after biofeedback training. "
09/01/1991 - "The clinical utility of Tellegen's Absorption Scale was examined using a sample of 32 chronic vascular headache patients drawn from a larger treatment study investigating the efficacy of thermal biofeedback with vascular headache. "
06/01/1990 - "This study investigates the use of biofeedback, relaxation and psychotherapy on five patients with severe, vascular headaches that occurred during the course of pregnancy. "
03/01/1989 - "Two studies of the potential mechanisms of action in the thermal biofeedback treatment of vascular headache."
09/01/1998 - "The authors conclude that: 1) patients who suffer from chronic occipital pain after having sustained injury obtain worthwhile benefit from microsurgical C-2 ganglionectomy; 2) patients suffering from migraine, tension, and vascular headaches involving the occipital area are most often not helped by this operation; and 3) terms such as "shock," "electric," "shooting," "jabbing," and "sharp" used to describe occipital pain predict a favorable pain outcome following a C-2 ganglionectomy."
|3.||Drug Therapy (Chemotherapy)